Original Articles Open Access
Copyright ©The Author(s) 2000. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 15, 2000; 6(5): 699-703
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.699
Chemoprevention of tea on colorectal cancer induced by dimethylhydrazine in Wistar rats
Xu Dong Jia, Chi Han, Department of Food Toxicology, Institute of Nutrition and Food Hygiene, Beijing 100050, China
Xu Dong Jia, graduated from Chinese Academy of Preventive Medicine in 1999. Now he is pursuing his Ph.D. degree at Chinese Academy of Preventive Medicine, having three papers published.
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Chi Han, Department of Food Toxicology, Institute of Nutrition and Food Hygiene, 29 Nanwei Road, Beijing 100050, China
Telephone: 0086-10-63170616 Fax: 0086-10-63011875
Received: May 25, 2000
Revised: June 16, 2000
Accepted: June 23, 2000
Published online: October 15, 2000

Abstract

AIM: To investigate the chemopreventive effects of green tea and tea pigment on 1,2-dimethylhydrazine (DMH)-induced rat colorectal carcinogenesis.

METHODS: Male weaning Wistar rats were randomly allocated into four groups. Rats in the positive control group were given s.c. injection of DMH, once a week for ten weeks; rats in tea-treated groups, with the same DMH treatment as in the positive group, received 2% green tea and 0.1% tea pigments; rats in the negative control group were given s.c. injection of the same volume of saline as well as DMH in the positive group. Animals were sacrified and necropsied at the end of week 16 and week 32.

RESULTS: Aberrant cryptic foci (ACF) were formed in animals in DMH-treated groups at the end of week 16. Compared to the DMH group, green tea and tea pigments groups had less ACF (148.25 and 204.25, respectively, P < 0.01). At the end of week 32, all rats in DMH group developed large intestinal tumors. The results also showed that DMH increased labeling index (LI) of proliferating cell nuclear antigen (PCNA) of intestinal mucosa and the expression of ras-p21. However, in the tea-treated groups, PCNA-LI was significantly reduced as compared with the positive control group (36.63 and 40.36 in the green tea group and tea pigment group, respectively, at the end of the experiment, P < 0.01). ras-p21 expression was also signific antly reduced (2.07 and 2.36 in the colon tumors of rats in the green tea group and tea pigments group, respectively at the end of the experiment, P < 0.01). Furthermore, green tea and tea pigment inhibited the expression of Bcl-2 protein (2, 5, 1, 0 and 2, 4, 1, 0, respectively, at the end of the experiment P < 0.01), and induced expression of Bax protein (0, 1, 3, 4 and 0, 1, 4, 3, respectively, P < 0.01).

CONCLUSION: Chinese green tea drinking inhibited ACF and colonic tumors formation in rats, which showed that tea had a significant chemopreventive effect on DMH-induced colorectal carcinogenesis. Such effects may be due to suppression of cell proliferation and induction of apoptosis in the intestinal crypts.

Key Words: colorectal neoplasms; dimethylhydrazine; tea; apoptosis; aberant crypt foci; rats; proliferating cell nuclear antigen; chemoprevention



INTRODUCTION

Colorectal cancer is the third most common malignant neoplasm worldwide[1]. In China, the incidence and mortality rates of colorectal cancer are increasing in recent decade, being the fifth leading cause of cancer deaths[2].

Aberrant crypt foci (ACF) in the colonic mucosa have been hypothesized to represent precursor lesions of chemically induced colon cancer. Aberrant crypts can be identified by their increased size, thicker epithelial lining, and increased pericryptal zone[3]. Various studies have supported the concept that ACF are precancerous lesions that can be used as biologic end points in the study of modulators of colon caucinogenesis[4-9].

Tea is one of the most popular beverages consumed worldwide. Tea polyphenols is the major constituent of green tea, whereas tea pigments, the major constituent of black tea, is a compound which is mainly composed of teaflavin and tearubigin. Many studies on the possible modifying effect of green tea and tea polyphenols on experimentally induced colorectal cancer have been carried out during the last decades[10], but there are few reports about the effect of black tea and tea pigments.

Carcinogen-induced ACF formation in rodent colon has been used as a short-term bioassay to evaluate the role of nutritional elements and to screen potentially new chemopreventive agents[11], however, few reports have been found regarding the early detection of ACF corresponding to the later development of tumors[12]. The purpose of our present study is to find out the effects of green tea and tea pigments on ACF formation and colorectal cancer induced by DMH in Wistar rats, and to appraise their possible mechanisms.

MATERIALS AND METHODS
Materials

Green tea and tea pigments were provided by the Institute of Tea Science and Research, Chinese Academy of Agricultural Sciences. The water extract of green tea was prepared freshly everyday as follows: 2 g of green tea leaves (Long Jing brand) was dissolved in 100 mL boiling water, allowed to stand at room temperature for 30 minutes, and then filtered. Tea pigment solution was prepared freshly daily.

Animals and treatment

168 weaning male Wistar rats were purchased from the Animals Breeding Center of Chinese Academy of Medical Sciences, Beijing, and were randomly allocated into four groups, 42 rats in each. The animals were maintained in a controlled environment at 24 °C ± 1 °C and 50% ± 10% relative humidity with an altering 12:12-hour light-dark cycle. Rats in group 1 (positive control) were given s.c. injection of DMH-2HCl (Sigma Chemical) once weekly for 10 weeks at a dose of 20 mg/kg body weight. Animals in groups 2 and 3, in addition to the same carcinogen treatment as in group 1, received 2% green tea and 0.1% tea pigments, respectively, as the sole source of drinking fluid. Animals in group 4 (negative control group) were injected s.c. with equal volumes of physiological saline. Rats in group 1 and group 4 were given tap water as drinking fluid. Body weight of all animals was recorded weekly until the last DMH injection , and then every 4 weeks until the end of the study. The daily consumption of tea and water were also recorded. Animals were killed at weeks 16 and 32. The colons were rapidly removed and opened longitudinally, cleaned with cold saline, fixed in 10% formalin, dehydrated and embedded in paraffin, Five-µm-thick sections were processed for histopathological examination for proliferating cell nuclear antigen (PCNA) analysis, and bcl-2 and bax analysis. For ras-p21 analysis, colonic mucosa were scraped with a microscope slide and stored at -80 °C until used. The number of tumors were counted and the length (L), width (W) and height (H) of each tumor were measured to calculate the tumor volume (V = L × W × H ×π/6).

Quantification of ACF

ACF were quantified following the protocol established by McLellan and colleagus[13]. Fixed colon specimens were stained in 0.02% methylene blue, and the number and growth of ACF were assessed under the light microscope. Criteria used to identify the ACF included: ① increased size, ② thicker epithelial cell layer, and ③ increased pericryptic zone. To determine crypt multiplicity, ACF were further categorized as small (1-3 crypts/focus), medium (4-6 crypts/focus), and large (≥ 7 crypts/focus).

Immunohistochemical analysis of PCNA

Two deparafinized sections were used for PCNA staining by using a Straptavidin/Peroxidase (SP) kit (ZYMED). Following the instructions, the anti-PCNA monoclonal antibody (mouse anti rat, ZYMED) was diluted with antibody-diluting buffer (1:100) and used for tissue sections.

The PCNA labeling index (LI) was determined by identifying 10 well-oriented crypts in which the base, lumen, and the apex of crypts displayed a U-shaped configuration. The PCNA-LI was calculated as the number of positive cells per crypt divided by the total number of cells per crypt multiplied by 100.

Measurement of ras-p21 expression

The expression of ras-p21 was detected by Western blot[14]. Briefly, colonic mucosa and tumor specimens were washed in ice-cold phosphate-buffered saline (PBS) and suspended in disruption buffer. The specimens were homogenized and left on ice for 30 min. The extracts were purified by centrifugation at 12000 × g for 20 min at 4 °C.

Clear extracts of colonic mucosa and tumors corresponding to 100 µg total protein were subjected to SDS-PAGE according to the method of Laemmli[15]. The separated protein was then transfered nitrocellulose membrane and detected with mouse monoclonal antibody pan-ras. Densitometric analysis of immunoblots were then performed for quantification of each band.

Immunohistochemical analysis of Bcl-2 and Bax

Bcl-2 and Bax were stained using the same method as PCNA staining except using the rabbit polyclonal Bcl-2 antibody (ZYMED) in 1:100 dilution and rabbit polyclonal Bax antibody (ZYMED) in 1:100 dilution.

Positive cells were quantified by two independent observers, expressed as the percentage of the total number of cells, and assigned to one of 4 categories: 1, 0%-25%; 2, 25%-50%; 3, 50%-75%; and 4, 75%-100%.

Statistical analysis

Body weight, tea consumption, number of ACF, number of tumors, PCNA-LI and ras-p21 expression among the 4 groups were compared by Student’s t test. Tumor volumes and the grading of Bcl-2 and Bax expression were compared by the Wilcoxon-rank test.

RESULTS
General observations

Table 1 presentes the body weight of the 4 groups of animals. At the end of week 32, then compared with the negative control group, the body weights in the other three groups (DMH-treated) decreased. However, analysis of the data revealed no significant differences between them. In addition, the quantity of tea and water consumption in 4 the groups were also not significantly different.

Table 1 Body weights during the study (x-± s).
Treatment groupsWeek 0Week 16Week 32
DMH70.14 ± 5.92425.69 ± 44.06456.25 ± 94.36
Green tea + DMH69.73 ± 6.25427.60 ± 44.11459.19 ± 95.52
Tea pigments + DMH70.23 ± 5.35425.39 ± 46.99463.24 ± 98.50
Negative control69.62 ± 6.20430.89 ± 47.36487.31 ± 99.58
ACF formation

ACF was formed in DMH-treated groups (groups 1-3), but there was no ACF formation in the negative control group (group 4). Compared with the positive control group (group 1), the total number of ACF per colon in tea-treated groups 2 and 3 decreased significantly (P < 0.01). Small, medium and large ACF in tea-treated groups were also significantly different from group 1 (Table 2).

Table 2 Effect of tea on DMH-induced ACF (x-± s).
Treatment groupsTotalSmallMediumLarge
DMH249.88 ± 10.89161.50 ± 8.0763.75 ± 1.8524.62 ± 2.87
Green tea + DMH148.25 ± 14.05a91.75 ± 12.63a44.10 ± 1.80a12.50 ± 1.58a
Tea pigments + DMH204.25 ± 11.94a126.50 ± 10.37a53.00 ± 2.24a17.38 ± 3.04a
Negative control0000
Cancer formation

The results of cancer formation are listed in Table 3. At the end of the experiment, all rats in the positive group developed colonic cancer, but none was developed in the negative control group. Animals that consumed 2% green tea and 0.1% tea pigments had significantly fewer cancer than that of the positive control group, and the mean volume also dramatically lower.

Table 3 Effect of tea on DMH-induced colon tumors.
Treatment groupsnanbAverage number of tumors per ratMean tumor volume
DMH20202.55 ± 1.36294.69 ± 614.43
Green tea + DMH20141.35 ± 1.27c66.87 ± 58.20d
Tea pigments + DMH20161.45 ± 1.16c94.83 ± 120.89d
Negative control20000
Immunohistochemical analysis of PCNA

Table 4 shows the immunohistochemical analysis of PCNA-LI. After 16 and 32 weeks, the PCNA-LI in DMH-treated groups increased significantly over the negative control group. Oral administration of 2% green tea and 0.1% tea pigments diminished the PCNA-LI (P < 0.01).

Table 4 Effect of tea on PCNA-LI in colonic mucosa of DMH-treated rats (x-± s).
Treatment groupsPCNA-LI
Week 16 (n = 8)Week 32 (n = 8)
DMH41.75 ± 6.0152.53 ± 5.40
Green tea + DMH22.02 ± 3.63a36.63 ± 5.41a
Tea pigments + DMH29.66 ± 2.65a40.36 ± 5.64a
Negative control14.34 ± 4.6815.43 ± 5.08
Western blot analysis of ras-p21 expression

Table 5 summarizes the results of Western blot analysis for ras-p21 expression in both colonic mucosa and the cancers. At the end of weeks 16 and 32, Green tea and tea pigments significantly suppressed the expression of ras-p21 in colonic mucosa and cancer as compared with the positive control group (P < 0.01).

Table 5 Effect of tea on expression levels of ras-p21(x-± s).
Treatment groupsras-p21 expression
Week 16 (n = 8)Week 32 (n = 8)Week 32 (n = 8)
colonic mucosacolonic mucosacolon tumors
DMH2.03 ± 0.352.26 ± 0.283.16 ± 0.32
Green tea + DMH1.36 ± 0.14a1.48 ± 0.12a2.07 ± 0.15a
Tea pigments + DMH1.51 ± 0.19a1.72 ± 0.15a2.36 ± 0.16a
Negative control111
Bcl-2 and Bax expression

The results of immunohistochemical analysis of Bcl-2 and Bax expression are shown in Table 6 and Table 7. At the end of weeks 16 and 32, Bcl-2 expression was significantly suppressed in tea-treated groups as compared with the positive control group, while Bax expression was significantly induced in groups 2 and 3 (P < 0.05 or P < 0.01).

Table 6 Effect of tea on Bcl-2 expression.
Treatment groupsWeek 16 (n = 8)
Week 32 (n = 8)
IIIIIIIVaIIIIIIIV
DMH11330125
Green tea + DMH2510b2510c
Tea pigments + DMH1511b2420c
Negative control62005300
Table 7 Effect of tea on Bax expression.
Treatment groupsWeek 16 (n = 8)
Week 32 (n = 8)
IIIIIIIVaIIIIIIIV
DMH25103500
Green tea + DMH0152b0134c
Tea pigments + DMH0341b0143c
Negative control62005300
DISCUSSION

It is recognized that colon carcinogenesis is a multistep process that includes sequential selection and propagation of preneoplastic lesions. ACF are present in carcinogen-treated rodent colons as well as in humans at high risk for colon cancer development and in patients with colon cancer[16,17]. Several studies investigating the genotypic, morphological, and growth features of ACF have supported the contention that ACF are preneoplastic lesions[4]. The ACF system is frequently used to identify and study the modulation of colon carcinogenesis. The results of the present study indicated drinking 2% green tea and 0.1% tea pigments significantly inhibited the formation of ACF, and decreased significantly the numbers and size of tumor. Some epidemiologic studies revealed an inhibitory effect of green tea on the incidence of colorectal cancer[18,19]. In addition, many experimental studies have demonstrated that green tea and tea polyphenols have significant inhibitory effects on rodent colorectal carcinogenesis[20]. Our study also demonstrated that 2% green tea significantly inhibited DMH-induced ACF formation and colorectal cancer. Black tea consists of significant amount of tea pigments including teaflavins, tearubigins, etc. Teaflavins have antioxidative and antimutagenic effects[21]. However, very few studies on animal tumorigenesis model have been reported. Morse et al[22] demonstrated that eaflavins in drinking water reduced esophageal tumor induced by N-nitrosomethylbenzylamine (NMBzA) in rats. We have observed that tea pigments have significant inhibitory effects on oral carcinogenesis[23]. The present study demonstrated that as little as 0.1% tea pigments could significantly inhibit colorectal tumor induced by DMH in rats. It has been suggested that tea pigments may play important roles on the protective effect of black tea in chemical carcinogenesis models.

Abnormal cellular proliferation is one of crucial mechanisms in carcinogenesis[24]. PCNA is an auxiliary protein of the DNA polymerase delta, reaching an expression peak during the S-phase of the cell cycle and playing an important role in cellular proliferation[25,26]. PCNA-LI has been used as an intermediate biomarker in chemoprevention of colorectal cancer[27]. Zheng et al[28] observed that vitamin A significantly decreased PCNA-LI in the AOM-induced colorectal cancer animal model. Another study gave similar result[29]. In this study, both green tea and tea pigments significantly inhibited PCNA-LI at the end of weeks 16 and 32.

Recent evidence indicates that activation of ras proto-oncogenes, coupled with the loss or inactivation of suppressor genes induces a malignant phenotype in colonic cells[30]. The ras proto-oncogenes (c-Ki-ras, c-Ha-ras and N-ras) constitute a family of highly conserved genes encoding a structurally and functionally related 21 kd protein, referred to as ras-p21, which is anchored to the cytoplasmic face of the plasma membrane, binds to the guanine nucleotides GTP and GDP. Ras activation represents one of the earliest and most frequently occurring genetic alterations associated with human cancers, especially in cancer of colon[31-34]. Elevated levels of ras-p21 were correlated with increased cell proliferation, histological grading, nuclear anaplasia and degree of undifferentiation[35,36]. In experiments where mutated ras genes are selectively inactivated, the pre -existing tumor phenotype reverts to a more normal form, indicating activated ras may be necessary for the maintenance of malignant behavior[37]. Recent studies have demonstrated a strong correlation between dietary modulation of carcinogen-induced ras activation and consequent tumor outcome[38]. Singh et al[39] had suggested that determination of ras-p21 might be a useful marker to evaluate the effectiveness of tumor inhibitory properties in colon carcinogenesis. In this study, the DMH-induced expression of ras-p21 was significantly suppressed both in tumors and in uninvolved colonic mucosa by oral feeding of 2% green tea and 0.1% tea pigments.

Colorectal cancer is believed to result from a series of genetic alterations that destroys normal mechanisms controlling the cell growth[30,40]. Apoptosis or programmed cell death appears to be an important mechanism in deletion of tumor cells rather than increased cell proliferation[41-43]. The bcl-2 proto-oncogene is a known inhibitor of apoptosis and may therefore allow an accumulation of genetic alterations that become propagated by cell division and potentially contribute to neoplastic development[44-46]. The bcl-2 gene encodes a 25 kd protein that localizes to the mitochondrial membrane, nuclear envelope, and endoplasmic reticulum[47]. Sinicrope et al[48] analyzed the expression of Bcl-2 oncoprotein during colorectal tumorigenesis and concluded that abnormal activati on of bcl-2 gene appeared to be an early event on colorectal tumorigenesis that can inhibit apoptosis in vivo and may facilitate tumor progression. Increased bcl-2 expression could occur in conjunction with changes in the expression of other members of the bcl-2 family, including those counteract the antiapoptotic effects of Bcl-2. One candidate in this regard is Bax, a dominant repressor of Bcl-2 that forms heterodimers with Bcl-2 and accelerates rates of cell death[49,50]. A recent study found that the development of IQ induced colorectal tumors was accompanied by the progressive inhibition of programmed cell death which was associated with increased expression of the antiapoptosis protein Bcl-2 and decreased expression of Bax[51]. In our study, the expression of Bcl-2 was inhibited significantly by oral 2% green tea and 0.1% tea pigments, while the expression of Bax was induced significantly. The results demonstrated that green tea and tea pigments induced apoptosis.

In conclusion, the present study indicated that green tea and tea pigments significantly inhibited ACF and colorectal cancer induced by DMH, and our study further supported the hypothesis that ACF are precancerous lesions of colorectal cancer and the ACF system can be used as a short-term bioassay to screen potentially new chemopreventive agents and to evaluate the effect of protective factors at a very early stage of the carcinogenic process. Although the mechanisms of the inhibitory effects of tea preparations on carcinogen-induced colorectal carcinogenesis have not been fully elucidated, our study showed that inhibition of proliferation and induction of apoptosis may be two important mechanisms.

ACKNOWLEGEMENTS

We thank Dr. Qi-Kun Chen of the Institute of Tea Science and Research, Chinese Academy of Agricultural Science for his generous offer of tea samples, and are also grateful to Dr. Chung S. Yang of Rutgers University for his kind review of our manuscript.

Footnotes

Edited by Wu XN Proofread by Zhu LH and Ma JY

References
1.  Shike M, Winawer SJ, Greenwald PH, Bloch A, Hill MJ, Swaroop SV. Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990;68:377-385.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Li LD, Lu FZ, Zhang SW. Analysis of malignant tumors in China during 1990-1992. Zhonghua Zhongliu Zazhi. 1996;18:404-407.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37:147-151.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 740]  [Cited by in F6Publishing: 717]  [Article Influence: 19.4]  [Reference Citation Analysis (0)]
4.  Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995;93:55-71.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 409]  [Cited by in F6Publishing: 398]  [Article Influence: 13.7]  [Reference Citation Analysis (0)]
5.  Bird RP. Effect of cholic acid on the number and growth of aberrant crypt foci: putative preneoplastic lesions. Proc Am Assoc Cancer Res. 1991;32:76.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Archer MC, Bruce WR, Chan CC, Corpet DE, Medline A, Roncucci L, Stamp D, Zhang XM. Aberrant crypt foci and microadenoma as markers for colon cancer. Environ Health Perspect. 1992;98:195-197.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Bird RP. Further investigation of the effect of cholic acid on the induction, growth characteristics and stability of aberrant crypt foci in rat colon. Cancer Lett. 1995;88:201-209.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Bird RP, McLellan EA, Bruce WR. Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv. 1989;8:189-200.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Bird RP, Pretlow TP. Letter to the Editor. Cancer Res. 1992;52:4291-4292.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Yang CS, Wang ZY. Tea and cancer. J Natl Cancer Inst. 1993;85:1038-1049.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 764]  [Cited by in F6Publishing: 690]  [Article Influence: 22.3]  [Reference Citation Analysis (0)]
11.  Pereira MA, Barnes LH, Rassman VL, Kelloff GV, Steele VE. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis. 1994;15:1049-1054.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 147]  [Cited by in F6Publishing: 149]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
12.  Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis. 1992;13:1509-1512.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 198]  [Cited by in F6Publishing: 202]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
13.  McLellan EA, Bird RP. Specificity study to evaluate induction of aberrant crypts in murine colons. Cancer Res. 1988;48:6183-6186.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res. 1997;57:253-258.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 185380]  [Cited by in F6Publishing: 188218]  [Article Influence: 3485.5]  [Reference Citation Analysis (0)]
16.  Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurcisek JA, Stellato TA. Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res. 1991;51:1564-1567.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Zhu RM, Zhang YS. A new precancerous lesion of colorectal cancer: aberrant crypt foci. Xin Xiaohuabingxue Zazhi. 1997;5:264-265.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Kato I, Tominaga S, Matsuura A, Yoshii Y, Shirai M, Kobayashi S. A comparative case-control study of colorectal cancer and adenoma. Jpn J Cancer Res. 1990;81:1101-1108.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res. 1988;79:1067-1074.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 205]  [Cited by in F6Publishing: 209]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
20.  Yamane T, Hagiwara N, Tateishi M, Akachi S, Kim M, Okuzumi J, Kitao Y, Inagake M, Kuwata K, Takahashi T. Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Jpn J Cancer Res. 1991;82:1336-1339.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 105]  [Cited by in F6Publishing: 106]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
21.  Shiraki M, Hara Y, Osawa T, Kumon H, Nakayama T, Kawakishi S. Antioxidative and antimutagenic effects of theaflavins from black tea. Mutat Res. 1994;323:29-34.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 122]  [Cited by in F6Publishing: 129]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
22.  Morse MA, Kresty LA, Steele VE, Kelloff GJ, Boone CW, Balentine DA, Harbowy ME, Stoner GD. Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis. Nutr Cancer. 1997;29:7-12.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 40]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
23.  Li N, Han C, Chen J. Tea preparations protect against DMBA-induced oral carcinogenesis in hamsters. Nutr Cancer. 1999;35:73-79.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Weinstein IB. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture. Cancer Res. 1988;48:4135-4143.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990;162:285-294.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1079]  [Cited by in F6Publishing: 1128]  [Article Influence: 33.2]  [Reference Citation Analysis (0)]
26.  Wang YK, Ji XL, Gu YG, Zhang SC, Xiao JH. P53 and PCNA expression in glandular dilatation of gastric mucosa. China Natl J New Gastroenterol. 1996;2:106-108.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Zhang XQ. Progress of study on suppresser, EGFR and PCNA in colorectal cancer. Xin Xiaohuabingxue Zazhi. 1996;4:327-328.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Zheng Y, Kramer PM, Olson G, Lubet RA, Steele VE, Kelloff GJ, Pereira MA. Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats. Carcinogenesis. 1997;18:2119-2125.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 43]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
29.  Adams WJ, Lawson JA, Nicholson SE, Cook TA, Morris DL. The growth of carcinogen-induced colon cancer in rats is inhibited by cimetidine. Eur J Surg Oncol. 1993;19:332-335.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8087]  [Cited by in F6Publishing: 7871]  [Article Influence: 231.5]  [Reference Citation Analysis (1)]
31.  Barbacid M. ras oncogenes: their role in neoplasia. Eur J Clin Invest. 1990;20:225-235.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 165]  [Cited by in F6Publishing: 187]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
32.  Fang DC, Luo YH, Lu R, Men RP, Jin HY. Study on the relation between H-ras gene point mutation and the prognosis of patients with gastric cancer. Xin Xiaohuabingxue Zazhi. 1994;2:80-81.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Xu L, Lu GY. Analysis of ras p21 and DNA contents in colorectal cancer. Shijie Huaren Xiaohua Zazhi. 1999;7:706-707.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Luo D, Liu QF, Gove C, Naomov N, Su JJ, Williams R. Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas. World J Gastroenterol. 1998;4:97-99.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Kotsinas A, Spandidos D, Romanowski P, Wyllie A. Relative expression of wild-type and activated ki-ras2 oncogene in colorectal carcinomas. Int J Oncol. 1993;3:841-845.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Fang DC, Liu WW. Immunohistochemical detection of ras oncogene product P21 in gastric cancer and its precancerous lesions. Xin Xiaohuabingxue Zazhi. 1994;2:225-226.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res. 1991;51:1744-1748.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Llor X, Jacoby RF, Teng BB, Davidson NO, Sitrin MD, Brasitus TA. K-ras mutations in 1,2-dimethylhydrazine-induced colonic tumors: effects of supplemental dietary calcium and vitamin D deficiency. Cancer Res. 1991;51:4305-4309.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res. 1997;57:253-258.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4616]  [Cited by in F6Publishing: 4417]  [Article Influence: 122.7]  [Reference Citation Analysis (0)]
41.  Wyllie AH. The biology of cell death in tumours. Anticancer Res. 1985;5:131-136.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Sun YX, Zhou HG, Xie DY, Shi YQ. Intestinal tumors and apoptosis. Xin Xiaohuabingxue Zazhi. 1997;5:791-792.  [PubMed]  [DOI]  [Cited in This Article: ]
43.  Huang PL, Zhu SN, Lu SL, Dai ZS, Jin YL. Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells. World J Gastroenterol. 2000;6:295-297.  [PubMed]  [DOI]  [Cited in This Article: ]
44.  Liu HF, Liu WW, Fang DC, Men RP. Expression of bcl-2 protein in gastric carcinoma and its significance. World J Gastroenterol. 1998;4:228-230.  [PubMed]  [DOI]  [Cited in This Article: ]
45.  Yang XJ, Chen SB, Bao JZ, Wang Y, Zhang ZB, Zhang XK, Zhang XR. Effect of HGF on etoposide induced apoptosis and bcl-2 gene expression for hepatocellular carcinoma. Xin Xiaohuabingxue Zazhi. 1997;5:518-519.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Cao JW, Luo HS. Bcl 2 gene family and gastrointestinal tumors. Xin Xiaohuabingxue Zazhi. 1997;5:734-735.  [PubMed]  [DOI]  [Cited in This Article: ]
47.  Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 1993;53:4701-4714.  [PubMed]  [DOI]  [Cited in This Article: ]
48.  Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995;55:237-241.  [PubMed]  [DOI]  [Cited in This Article: ]
49.  Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-619.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4399]  [Cited by in F6Publishing: 4472]  [Article Influence: 144.3]  [Reference Citation Analysis (0)]
50.  Liu HF, Liu WW, Fang DC, Men RP. Expression and significance of proapoptotic gene Bax in gastric carcinoma. World J Gastroenterol. 1999;5:15-17.  [PubMed]  [DOI]  [Cited in This Article: ]
51.  Hayashi R, Luk H, Horio D, Dashwood R. Inhibition of apoptosis in colon tumors induced in the rat by 2-amino-3-methylimidazo[4,5-f]quinoline. Cancer Res. 1996;56:4307-4310.  [PubMed]  [DOI]  [Cited in This Article: ]